CRA’s Competition Practice advised UnitedHealth Group in connection with the US Department of Justice’s (DOJ) review of UnitedHealth’s $3.3 billion acquisition of Amedisys.
The DOJ, which had initially sought to block the transaction, announced that it reached a settlement with UnitedHealth and Amedisys, enabling the deal to proceed. UnitedHealth and Amedisys both provide home health and hospice services, employing nurses to deliver in-home care to patients across the US.
The settlement follows two years of regulatory review since the transaction was first announced in the summer of 2023. The DOJ’s press release is available here.
CRA’s Competition team provided its expertise throughout the DOJ’s investigation and litigation proceedings. The engagement team was led by Sean May and Sandra Chan and included Joshua Lustig, Yajing Jiang, and Benjamin Stearns.
